feed,title,long_url,short_url
Motley,AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why,https://www.fool.com/investing/2023/12/26/abbvies-immunogen-acquisition-looks-brilliant/?source=iedfolrf0000001,https://da.gd/m9Fp5
